Replies to post #204300 on NorthWest Biotherapeutics Inc (NWBO)

[Virgilio]

This is a key point. I do believe and hope that they will agree to change the primary endpoint to OS.

[monentum2play]

Thank what LL says is gold. Something need to be done to recognize end points quicker. That why so many imunotherapy trials failed. Still management in conveying information to their investors is terrible and this excuse about short exists but every biotech gets attacked to pennies. Look at the OTC it is up to manegement to foresee and have a defensive plan..